SUD 0.00% 4.2¢ suda pharmaceuticals ltd

ZolpiMist, page-7

  1. 5,152 Posts.
    lightbulb Created with Sketch. 176
    From SUDA Announcement 13 November 2018

    (Just another timeline missed)

    In Australia, SUDA is working with its regulatory consultants to finalise its MarketingApplication to the Australian Therapeutic Goods Administration for the approval ofZolpiMist in the Australian market. It is anticipated that the application should be lodgedwith the TGA in January 2019.
    SUDA is now looking for a partner for the Australian market.
 
watchlist Created with Sketch. Add SUD (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.